Systematic Reviews & Meta-analysis
Systematic Review: Partial breast irradiation versus whole breast radiotherapy for early breast cancer.
15 Sep, 2021 | 08:46h | UTC
Commentary on Twitter
https://twitter.com/CochraneUK/status/1433703573402046467
Systematic review finds there is insufficient evidence that AI breast cancer screening is accurate enough to replace human scrutiny.
10 Sep, 2021 | 05:12h | UTCOriginal study: Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy – The BMJ
Commentary on Twitter
A systematic review of #AI for mammography is very disappointing
"Thirty four (94%) of 36 AI systems evaluated in these studies were less accurate than a single radiologist, and all were less accurate than consensus of two or more radiologists"https://t.co/zqFTxojU9J @bmj_latest pic.twitter.com/wylwOsf4ua— Eric Topol (@EricTopol) September 2, 2021
Editorial | Anticholinergic drugs and dementia: time for transparency in the face of uncertainty.
9 Sep, 2021 | 08:57h | UTCSystematic review: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library
Commentary on Twitter
Anticholinergic drugs may double the risk of developing dementia. What should we be doing right now?
Editorial with @JenMStevenson for @CochraneLibrary published todayhttps://t.co/808wSGPUtm— Henry Woodford (@woodford_henry) September 8, 2021
Tube feeding for people with severe dementia: making decisions.
7 Sep, 2021 | 10:39h | UTCTube feeding for people with severe dementia: making decisions – Evidently Cochrane
Systematic review: evaluation of dietary patterns and all-cause mortality.
6 Sep, 2021 | 10:43h | UTCEvaluation of Dietary Patterns and All-Cause Mortality: A Systematic Review – JAMA Network Open
Commentary on Twitter (thread – click for more)
Great to see work focused on diet patterns (rather than single nutrient/foods)
Nutrient-dense diet patterns, regardless of pattern label/name (Med Diet, DASH, HEI, "plant-based"), were associated with significantly lower risk of death
Commonalities?👇https://t.co/yQxo4lNJNQ
— Stephan van Vliet (@vanvlietphd) September 1, 2021
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
6 Sep, 2021 | 10:45h | UTCInvited commentary: Integrated approach to stroke burden: are we doing enough? (free registration required)
Commentaries on Twitter
Released today! The analysis within @IHME_UW (@GBD) on #stroke #prevalence and the RFs of stroke has just been published in @TheLancetNeuro! The annual number of strokes (12,2 mln) and #deaths (6,5 mln) due to stroke increased substantially in lat 30 yrs. https://t.co/DUi7SYGyjt pic.twitter.com/7rVcrxZzNF
— Maciej Banach (@maciejbanach) September 3, 2021
📣 This new #GBDstudy released on @TheLancet examines the #global, regional, and national burden of #stroke and its risk factors
Findings:
▫️The annual number of strokes ⬆️ from 1990-2019
▫️2nd cause of death globally
▫️High Risk factor = high body-mass https://t.co/jnZauEH79M— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) September 3, 2021
M-A: Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia.
6 Sep, 2021 | 10:40h | UTCLong-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/TheLancetPsych/status/1382314592609693703
M-A: Effect of monthly injections of naltrexone on alcohol consumption.
6 Sep, 2021 | 10:39h | UTCEffect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis – Addiction (link to abstract – $ for full-text)
Musculoskeletal complications following critical illness: A scoping review.
3 Sep, 2021 | 10:07h | UTC
Commentary on Twitter
Very pleased that our scoping review on MSK complications following critical illness has been published – first paper from my PhD! @mawilliamsinOx @helendawes2 @matthewjrowland @ouh_therapies @MOReS_OBU #icurehab https://t.co/f6kHDtMzrj pic.twitter.com/bOm3YvLP5U
— Owen Gustafson (@OxfordICUPhysio) August 26, 2021
Treatment of urinary tract infections in infants <2 Months: A Living Systematic Review - short and long duration of parenteral antibiotics were associated with a similar risk of UTI recurrence.
2 Sep, 2021 | 08:19h | UTCTreatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics
Systematic review: In individuals with hemophilia A or B, there is evidence from RCTs that prophylaxis with clotting factor concentrates, as compared to on‐demand treatment, may reduce bleeding frequency.
2 Sep, 2021 | 08:17h | UTC
M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.
2 Sep, 2021 | 08:14h | UTC
Commentary on Twitter
The long, winding and expensive road leading to highly sensitive and specific noninvasive Dx of #NASH @Gut_BMJ https://t.co/ToIkF3yTAU
— Daniel J Drucker (@DanielJDrucker) May 25, 2021
M-A of randomized trials: Effectiveness of the modified Valsalva maneuver in adults with supraventricular – “The meta-analysis demonstrated a significantly higher success rate for reconversion to sinus rhythm when using the modified VM compared to the standard VM in patients with an SVT (odds ratio = 4.36; 95% confidence interval, 3.30–5.76; P < 0.001)”.
26 Aug, 2021 | 08:51h | UTCEffectiveness of the modified Valsalva manoeuvre in adults with supraventricular tachycardia: a systematic review and meta-analysis – European Journal of Emergency Medicine (link to abstract – $ for full-text)
Related: Randomized Trial: Standard Valsalva vs. Modified Valsalva for Cardioversion of SVT (studies and commentaries on the subject)
Video: Modified Valsalva manoeuvre for supraventricular tachycardia – The Lancet
Preventing stillbirth: What’s the latest evidence?
25 Aug, 2021 | 08:38h | UTCPreventing stillbirth: What’s the latest evidence? – Evidently Cochrane
Special collection: Stillbirth prevention and respectful bereavement care – Cochrane Library
Commentary on Twitter (thread – click for more)
New @CochraneLibrary Special Collection on #stillbirth prevention and respectful bereavement care: https://t.co/NW37SaUhr3 1/5#stillborn #babyloss #miscarriage #pregnancyloss #infantloss #pregnancyandinfantloss pic.twitter.com/mzIe3Sttwk
— The Cochrane Library (@CochraneLibrary) August 24, 2021
M-A: GLP-1 receptor agonists reduce major adverse cardiovascular events, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes.
22 Aug, 2021 | 22:50h | UTCCardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
M-A: The role of SGLT2 inhibitors in heart failure.
22 Aug, 2021 | 22:46h | UTCRelated:
ESC Position Paper: Cardiac, renal, and metabolic effects of SGLT2 inhibitors.
Summary: SGLT2 inhibitors and GLP-1 receptor agonists established and emerging indications.
M-A of randomized trials: The effect of higher versus lower protein delivery in critically ill patients – “In critically ill patients, a higher daily protein delivery was not associated with any improvement in clinical or patient-centered outcomes”.
20 Aug, 2021 | 08:57h | UTC
M-A: Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia.
20 Aug, 2021 | 09:04h | UTCExamination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis – JAMA Psychiatry (free for a limited period)
Commentaries on Twitter
Crucial literature review on optimal antipsychotic dosing for long term maintenance in #Schizophrenia.
Conclusion: Seek Goldilocks "just right"- definitely not high because of bad side effects, but not so low as to risk relapse.
Often easier said than done. https://t.co/RBBPBMzn9D
— Allen Frances (@AllenFrancesMD) August 20, 2021
Doses higher than 5mg/day risperidone equivalent are not more effective for relapse prevention than lower doses in #schizophrenia. But caution is required at the lower end of the dose-response curve where relapse risk disproportionally increases https://t.co/kQcnuRtzYU
— JAMA Psychiatry (@JAMAPsych) August 19, 2021
M-A: Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation.
20 Aug, 2021 | 09:01h | UTCPrevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients – European Heart Journal (link to abstract – $ for full-text)
Commentary on Twitter
AF-COMET Meta-analysis showed #COPD is common in #AF, being found in 13% of patients
📌⬆️ burden of comorbidities & worse outcomes
📌More than a two-fold ⬆️ risk of all-cause death
📌⬆️ Risk of CV death and major bleedinghttps://t.co/fLAuGkQAX1 @ESC_Journals @SchakrabartiEP pic.twitter.com/50OSfACH84— Henry Han (@HanCardiomd) August 2, 2021
Support surfaces for managing pressure ulcers: which to choose?
18 Aug, 2021 | 08:26h | UTCSupport surfaces for managing pressure ulcers: which to choose? – Evidently Cochrane
Systematic review: Systemic corticosteroids for the treatment of COVID‐19.
17 Aug, 2021 | 09:11h | UTCSystemic corticosteroids for the treatment of COVID‐19 – Cochrane Library
Commentary on Twitter (thread – click for more)
JUST PUBLISHED – Systemic #corticosteroids for the treatment of #COVID19 from @CochraneHaem – https://t.co/l4V993gLzj 1/5 pic.twitter.com/Vjk4aHXKFV
— The Cochrane Library (@CochraneLibrary) August 16, 2021
Systematic review: Enteral tube feeding for people with severe dementia – “We found no evidence that tube feeding improves survival; improves quality of life; reduces pain; reduces mortality; decreases behavioural and psychological symptoms of dementia”.
16 Aug, 2021 | 00:54h | UTCEnteral tube feeding for people with severe dementia – Cochrane Library
Summary: Enteral tube feeding for people with severe dementia – Cochrane Library
Related: Viewpoint: Tube Feeding and Deteriorating Patients (resources on the subject)
Commentary on Twitter
🚨🚨So happy our @CochraneUK review on enteral tube feeding in #dementia is now published – no evidence tube feeding improves #survival; improves quality of life; reduces #pain; reduces #mortality. But was evidence of increase risk of pressure ulcers https://t.co/uUHJEboNCd
— Nathan Davies (@NathanDavies50) August 13, 2021
Systematic review: Kinesio taping provides little or no benefit for rotator cuff disease.
16 Aug, 2021 | 00:52h | UTCKinesio taping for rotator cuff disease – Cochrane Library
Summary: Kinesio taping for rotator cuff disease – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1426468681677254658
M-A: Targeted temperature management following out-of-hospital cardiac arrest – “Routine use of moderate or deep hypothermia in comatose survivors of OHCA may potentially be associated with more harm than benefit”.
16 Aug, 2021 | 00:55h | UTCTargeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
#TTM post #OHCA, SR/NMA:
❄️deep, moderate & mild hypothermia not improve survival/functional outcome vs normothermia
❄️deep vs moderate hypothermia may not improve survival with good outcome
❄️higher incidence of arrhythmia with moderate & deep hypothermiahttps://t.co/Z18v5HSXyr pic.twitter.com/6TQf8QPKiA— Intensive Care Medicine (@yourICM) August 14, 2021
M-A: Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients.
13 Aug, 2021 | 09:01h | UTC
Commentary on Twitter
Preventing #delirium in #ICU SR/NMA
💉dexmedetomidine likely ⬇️ occurrence vs placebo & BDZs (moderate certainty)
💉sedation-minimization strategies vs BDZs may ⬇️ (uncertain)
💉DEX likely ⬇️ICU LoS vs placebo (moderate certainty) & vs antipsychotics (low)https://t.co/PWqKiyqLJz pic.twitter.com/QlANSH8icr— Intensive Care Medicine (@yourICM) August 13, 2021


